ID   S35A3_HUMAN             Reviewed;         325 AA.
AC   Q9Y2D2; A8K3F8; D3DT54; Q68CR2; Q9BSB7;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   15-MAR-2017, entry version 138.
DE   RecName: Full=UDP-N-acetylglucosamine transporter;
DE   AltName: Full=Golgi UDP-GlcNAc transporter;
DE   AltName: Full=Solute carrier family 35 member A3;
GN   Name=SLC35A3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10393322; DOI=10.1093/oxfordjournals.jbchem.a022437;
RA   Ishida N., Yoshioka S., Chiba Y., Takeuchi M., Kawakita M.;
RT   "Molecular cloning and functional expression of the human Golgi UDP-N-
RT   acetylglucosamine transporter.";
RL   J. Biochem. 126:68-77(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon carcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH SLC35A2.
RX   PubMed=23089177; DOI=10.1016/j.febslet.2012.10.016;
RA   Maszczak-Seneczko D., Sosicka P., Majkowski M., Olczak T., Olczak M.;
RT   "UDP-N-acetylglucosamine transporter and UDP-galactose transporter
RT   form heterologous complexes in the Golgi membrane.";
RL   FEBS Lett. 586:4082-4087(2012).
RN   [8]
RP   INVOLVEMENT IN AMRS.
RX   PubMed=24031089; DOI=10.1136/jmedgenet-2013-101753;
RA   Edvardson S., Ashikov A., Jalas C., Sturiale L., Shaag A., Fedick A.,
RA   Treff N.R., Garozzo D., Gerardy-Schahn R., Elpeleg O.;
RT   "Mutations in SLC35A3 cause autism spectrum disorder, epilepsy and
RT   arthrogryposis.";
RL   J. Med. Genet. 50:733-739(2013).
CC   -!- FUNCTION: Uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc)
CC       transporter in the Golgi apparatus. May supply UDP-GlcNAc as
CC       substrate for Golgi-resident glycosyltransferases that generate
CC       branching of diantennary oligosaccharides.
CC       {ECO:0000269|PubMed:10393322}.
CC   -!- SUBUNIT: Interacts with SLC35A2. {ECO:0000269|PubMed:23089177}.
CC   -!- INTERACTION:
CC       P78381-1:SLC35A2; NbExp=3; IntAct=EBI-3917581, EBI-8101118;
CC       P78381-2:SLC35A2; NbExp=2; IntAct=EBI-3917581, EBI-8101093;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:10393322}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10393322}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y2D2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y2D2-2; Sequence=VSP_012786;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9Y2D2-3; Sequence=VSP_054232, VSP_054233;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Arthrogryposis, mental retardation, and seizures (AMRS)
CC       [MIM:615553]: A disease characterized by arthrogryposis, mental
CC       retardation, autism spectrum disorder, and epilepsy. Additional
CC       features include limb malformations, distal joint involvement,
CC       microcephaly, retromicrognathia, and general muscle hypotonia.
CC       {ECO:0000269|PubMed:24031089}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. In Golgi
CC       vesicles isolated from patient fibroblasts the transport of the
CC       respective nucleotide sugar is significantly reduced causing a
CC       massive decrease in the content of cell surface expressed highly
CC       branched N-glycans and a concomitant sharp increase of lower
CC       branched glycoforms.
CC   -!- SIMILARITY: Belongs to the nucleotide-sugar transporter family.
CC       SLC35A subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB021981; BAA77841.1; -; mRNA.
DR   EMBL; AK290573; BAF83262.1; -; mRNA.
DR   EMBL; CR749816; CAH18676.1; -; mRNA.
DR   EMBL; AC118553; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471097; EAW72977.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72978.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72979.1; -; Genomic_DNA.
DR   EMBL; BC005136; AAH05136.1; -; mRNA.
DR   CCDS; CCDS60204.1; -. [Q9Y2D2-2]
DR   CCDS; CCDS60205.1; -. [Q9Y2D2-3]
DR   CCDS; CCDS762.1; -. [Q9Y2D2-1]
DR   RefSeq; NP_001258613.1; NM_001271684.1. [Q9Y2D2-3]
DR   RefSeq; NP_001258614.1; NM_001271685.1. [Q9Y2D2-2]
DR   RefSeq; NP_036375.1; NM_012243.2. [Q9Y2D2-1]
DR   RefSeq; XP_005270748.1; XM_005270691.4. [Q9Y2D2-1]
DR   RefSeq; XP_011539438.1; XM_011541136.2. [Q9Y2D2-1]
DR   UniGene; Hs.448979; -.
DR   UniGene; Hs.534953; -.
DR   ProteinModelPortal; Q9Y2D2; -.
DR   BioGrid; 117010; 2.
DR   IntAct; Q9Y2D2; 3.
DR   MINT; MINT-4781806; -.
DR   STRING; 9606.ENSP00000359174; -.
DR   TCDB; 2.A.7.12.7; the drug/metabolite transporter (dmt) superfamily.
DR   iPTMnet; Q9Y2D2; -.
DR   PhosphoSitePlus; Q9Y2D2; -.
DR   DMDM; 9087207; -.
DR   PaxDb; Q9Y2D2; -.
DR   PeptideAtlas; Q9Y2D2; -.
DR   PRIDE; Q9Y2D2; -.
DR   TopDownProteomics; Q9Y2D2-1; -. [Q9Y2D2-1]
DR   Ensembl; ENST00000370153; ENSP00000359172; ENSG00000117620. [Q9Y2D2-2]
DR   Ensembl; ENST00000427993; ENSP00000414947; ENSG00000117620. [Q9Y2D2-1]
DR   Ensembl; ENST00000465289; ENSP00000418527; ENSG00000117620. [Q9Y2D2-3]
DR   Ensembl; ENST00000533028; ENSP00000433849; ENSG00000117620. [Q9Y2D2-1]
DR   GeneID; 23443; -.
DR   KEGG; hsa:23443; -.
DR   UCSC; uc001dsp.3; human. [Q9Y2D2-1]
DR   CTD; 23443; -.
DR   DisGeNET; 23443; -.
DR   GeneCards; SLC35A3; -.
DR   HGNC; HGNC:11023; SLC35A3.
DR   HPA; HPA015253; -.
DR   MalaCards; SLC35A3; -.
DR   MIM; 605632; gene.
DR   MIM; 615553; phenotype.
DR   neXtProt; NX_Q9Y2D2; -.
DR   OpenTargets; ENSG00000117620; -.
DR   Orphanet; 370943; Autism spectrum disorder-epilepsy-arthrogryposis syndrome.
DR   PharmGKB; PA35891; -.
DR   eggNOG; KOG2234; Eukaryota.
DR   eggNOG; COG0697; LUCA.
DR   GeneTree; ENSGT00550000074563; -.
DR   HOGENOM; HOG000216649; -.
DR   HOVERGEN; HBG054025; -.
DR   InParanoid; Q9Y2D2; -.
DR   KO; K15272; -.
DR   OMA; NWAVWST; -.
DR   OrthoDB; EOG091G0CHS; -.
DR   PhylomeDB; Q9Y2D2; -.
DR   TreeFam; TF315345; -.
DR   Reactome; R-HSA-727802; Transport of nucleotide sugars.
DR   ChiTaRS; SLC35A3; human.
DR   GenomeRNAi; 23443; -.
DR   PRO; PR:Q9Y2D2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117620; -.
DR   CleanEx; HS_SLC35A3; -.
DR   ExpressionAtlas; Q9Y2D2; baseline and differential.
DR   Genevisible; Q9Y2D2; HS.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005351; F:sugar:proton symporter activity; IEA:InterPro.
DR   GO; GO:0005462; F:UDP-N-acetylglucosamine transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0006047; P:UDP-N-acetylglucosamine metabolic process; TAS:ProtInc.
DR   GO; GO:0015788; P:UDP-N-acetylglucosamine transport; IMP:UniProtKB.
DR   InterPro; IPR007271; Nuc_sug_transpt.
DR   PANTHER; PTHR10231; PTHR10231; 1.
DR   Pfam; PF04142; Nuc_sug_transp; 1.
DR   PIRSF; PIRSF005799; UDP-gal_transpt; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autism spectrum disorder; Complete proteome;
KW   Epilepsy; Golgi apparatus; Membrane; Mental retardation;
KW   Reference proteome; Sugar transport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    325       UDP-N-acetylglucosamine transporter.
FT                                /FTId=PRO_0000213357.
FT   TRANSMEM      8     24       Helical. {ECO:0000255}.
FT   TRANSMEM     42     58       Helical. {ECO:0000255}.
FT   TRANSMEM    138    154       Helical. {ECO:0000255}.
FT   TRANSMEM    173    189       Helical. {ECO:0000255}.
FT   TRANSMEM    209    225       Helical. {ECO:0000255}.
FT   TRANSMEM    246    262       Helical. {ECO:0000255}.
FT   TRANSMEM    268    284       Helical. {ECO:0000255}.
FT   TRANSMEM    295    311       Helical. {ECO:0000255}.
FT   VAR_SEQ       1      1       M -> MSSRSVLSPVVGTDAPDQHLELKKPQELKEMERLPL
FT                                ANEDKTM (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_012786.
FT   VAR_SEQ     212    220       GFFGSIFGL -> VSFSLEPSL (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054232.
FT   VAR_SEQ     221    325       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054233.
SQ   SEQUENCE   325 AA;  35985 MW;  69DFD944E37206C8 CRC64;
     MFANLKYVSL GILVFQTTSL VLTMRYSRTL KEEGPRYLSS TAVVVAELLK IMACILLVYK
     DSKCSLRALN RVLHDEILNK PMETLKLAIP SGIYTLQNNL LYVALSNLDA ATYQVTYQLK
     ILTTALFSVS MLSKKLGVYQ WLSLVILMTG VAFVQWPSDS QLDSKELSAG SQFVGLMAVL
     TACFSSGFAG VYFEKILKET KQSVWIRNIQ LGFFGSIFGL MGVYIYDGEL VSKNGFFQGY
     NRLTWIVVVL QALGGLVIAA VIKYADNILK GFATSLSIIL STLISYFWLQ DFVPTSVFFL
     GAILVITATF LYGYDPKPAG NPTKA
//
